<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39364503</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>16</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>Beyond Infection: Unmasking the Impact of COVID-19 on Diabetes Emergency Trends.</ArticleTitle><Pagination><StartPage>e68566</StartPage><MedlinePgn>e68566</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e68566</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.68566</ELocationID><Abstract><AbstractText>Introduction The relationship between COVID-19 and diabetes has been demonstrated in many studies. However, it is thought that the psycho-socioeconomic effects of the pandemic led to a worsening of glycemic control and an increase in diabetes-associated clinical emergencies in diabetic patients without a diagnosis of COVID-19. Objectives We aimed to reveal the change in the frequency of diabetes-related clinical emergencies before and during the COVID-19 pandemic. Patients and methods The data of the patients requiring endocrinology consultations in Manisa Celal Bayar University Faculty of Medicine Emergency Service between March 2018 and March 2022 were included. In total, 269 consultations were analyzed. The March 2018 - March 2020 period was considered as pre-COVID, and March 2020 - March 2022 as the COVID-19 period. The frequency of diabetes-related conditions between these two periods was compared. Results Compared to the pre-COVID period, there was a significant increase in the frequency of admissions with diabetic ketosis, hyperglycemic hyperosmolar state, hypoglycemia, and hyperglycemia in the COVID-19 period (p=0.022, p=0.037, p=0.044, and p=0.004 respectively). Although an increase was observed in the frequency of diabetic ketoacidosis (DKA) cases, no statistical significance was found. When the mortality data of the patients was evaluated, the total number of deaths was seen to increase significantly in the COVID-19 period (p=0.01). It was observed that the ratio of type 2 diabetes mellitus (DM)/type 1 DM among DKA patients increased significantly in the COVID-19 period (p=0.001). Conclusions It can be concluded that the increasing trend in diabetic emergencies that started even before the pandemic is exacerbated by COVID-19, especially in patients with poor glycemic control.</AbstractText><CopyrightInformation>Copyright © 2024, Güney et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Güney</LastName><ForeName>Sedat C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Endocrinology and Metabolism, Manisa Celal Bayar University, Manisa, TUR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Akçura</LastName><ForeName>Can</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Endocrinology and Metabolism, Manisa Celal Bayar University, Manisa, TUR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Alkan</LastName><ForeName>Samet</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Endocrinology and Metabolism, Manisa Celal Bayar University, Manisa, TUR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gelir Çavdar</LastName><ForeName>Gamze</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Endocrinology and Metabolism, İzmir City Hospital, İzmir, TUR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Özdemir</LastName><ForeName>Nilüfer</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Endocrinology and Metabolism, Manisa Celal Bayar University, Manisa, TUR.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hekimsoy</LastName><ForeName>Zeliha</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Endocrinology and Metabolism, Manisa Celal Bayar University, Manisa, TUR.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">coronavirus pandemic</Keyword><Keyword MajorTopicYN="N">covid-19</Keyword><Keyword MajorTopicYN="N">diabetes mellitus</Keyword><Keyword MajorTopicYN="N">diabetic emergencies</Keyword><Keyword MajorTopicYN="N">diabetic ketoasidosis</Keyword><Keyword MajorTopicYN="N">endocrinology consultations</Keyword><Keyword MajorTopicYN="N">hypoglycemia</Keyword></KeywordList><CoiStatement>Human subjects: Consent was obtained or waived by all participants in this study. Ethics Committee of Manisa Celal Bayar University Faculty of Medicine issued approval 20.478.486. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>8</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>8</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>4</Day><Hour>4</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>3</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39364503</ArticleId><ArticleId IdType="pmc">PMC11449498</ArticleId><ArticleId IdType="doi">10.7759/cureus.68566</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Early transmission dynamics in Wuhan, China, of novel coronavirus-infected pneumonia. Li Q, Guan X, Wu P, et al. N Engl J Med. 2020;382:1199–1207.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7121484</ArticleId><ArticleId IdType="pubmed">31995857</ArticleId></ArticleIdList></Reference><Reference><Citation>Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study. Holman N, Knighton P, Kar P, et al. Lancet Diabetes Endocrinol. 2020;8:823–833.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7426091</ArticleId><ArticleId IdType="pubmed">32798471</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19, hyperglycemia, and new-onset diabetes. Khunti K, Del Prato S, Mathieu C, Kahn SE, Gabbay RA, Buse JB. Diabetes Care. 2021;44:2645–2655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8669536</ArticleId><ArticleId IdType="pubmed">34625431</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 in relation to hyperglycemia and diabetes mellitus. Al-Kuraishy HM, Al-Gareeb AI, Alblihed M, Guerreiro SG, Cruz-Martins N, Batiha GE. Front Cardiovasc Med. 2021;8:644095.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8189260</ArticleId><ArticleId IdType="pubmed">34124187</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 and diabetes: a bidirectional relationship. Lima-Martínez MM, Carrera Boada C, Madera-Silva MD, Marín W, Contreras M. Clin Investig Arterioscler. 2021;33:151–157.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7598432</ArticleId><ArticleId IdType="pubmed">33303218</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical profile and outcomes in COVID-19 patients with diabetic ketoacidosis: a systematic review of literature. Pal R, Banerjee M, Yadav U, Bhattacharjee S. Diabetes Metab Syndr. 2020;14:1563–1569.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7434433</ArticleId><ArticleId IdType="pubmed">32853901</ArticleId></ArticleIdList></Reference><Reference><Citation>Characteristics of and mortality associated with diabetic ketoacidosis among US patients hospitalized with or without COVID-19. Pasquel FJ, Messler J, Booth R, Kubacka B, Mumpower A, Umpierrez G, Aloi J. JAMA Netw Open. 2021;4:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7948057</ArticleId><ArticleId IdType="pubmed">33688962</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 infection may cause ketosis and ketoacidosis. Li J, Wang X, Chen J, Zuo X, Zhang H, Deng A. Diabetes Obes Metab. 2020;22:1935–1941.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7264681</ArticleId><ArticleId IdType="pubmed">32314455</ArticleId></ArticleIdList></Reference><Reference><Citation>SARS-CoV-2 infection and associated rates of diabetic ketoacidosis in a New York City emergency department. Ditkowsky J, Lieber AC, Leibner ES, Genes N. West J Emerg Med. 2021;22:599–602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8203019</ArticleId><ArticleId IdType="pubmed">34125033</ArticleId></ArticleIdList></Reference><Reference><Citation>Incidence of diabetic ketoacidosis during COVID-19 pandemic: a meta-analysis of 124,597 children with diabetes. Elgenidy A, Awad AK, Saad K, et al. Pediatr Res. 2023;93:1149–1160.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9366798</ArticleId><ArticleId IdType="pubmed">35953513</ArticleId></ArticleIdList></Reference><Reference><Citation>Pathogenesis of diabetic ketoacidosis: a reappraisal. Schade DS, Eaton RP. Diabetes Care. 1979;2:296–306.</Citation><ArticleIdList><ArticleId IdType="pubmed">116831</ArticleId></ArticleIdList></Reference><Reference><Citation>ISPAD clinical practice consensus guidelines 2022: diabetic ketoacidosis and hyperglycemic hyperosmolar state. Glaser N, Fritsch M, Priyambada L, et al. Pediatr Diabetes. 2022;23:835–856.</Citation><ArticleIdList><ArticleId IdType="pubmed">36250645</ArticleId></ArticleIdList></Reference><Reference><Citation>The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery. Khunti K, Aroda VR, Aschner P, et al. Lancet Diabetes Endocrinol. 2022;10:890–900.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9640202</ArticleId><ArticleId IdType="pubmed">36356612</ArticleId></ArticleIdList></Reference><Reference><Citation>Serum cortisol concentration and COVID-19 severity: a systematic review and meta-analysis. Amiri-Dashatan N, Koushki M, Parsamanesh N, Chiti H. J Investig Med. 2022;70:766–772.</Citation><ArticleIdList><ArticleId IdType="pubmed">35058334</ArticleId></ArticleIdList></Reference><Reference><Citation>The impact of obesity on severe disease and mortality in people with SARS-CoV-2: a systematic review and meta-analysis. Seidu S, Gillies C, Zaccardi F, et al. Endocrinol Diabetes Metab. 2021;4:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7460942</ArticleId><ArticleId IdType="pubmed">32904932</ArticleId></ArticleIdList></Reference><Reference><Citation>Impact of COVID-19 on routine care for chronic diseases: a global survey of views from healthcare professionals. Chudasama YV, Gillies CL, Zaccardi F, Coles B, Davies MJ, Seidu S, Khunti K. Diabetes Metab Syndr. 2020;14:965–967.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7308780</ArticleId><ArticleId IdType="pubmed">32604016</ArticleId></ArticleIdList></Reference><Reference><Citation>Indirect effects of the COVID-19 pandemic on people with type 2 diabetes: time to urgently move into a recovery phase. Vamos EP, Khunti K. BMJ Qual Saf. 2022;31:483–485.</Citation><ArticleIdList><ArticleId IdType="pubmed">34686562</ArticleId></ArticleIdList></Reference><Reference><Citation>Changes in physical activity and sedentary behaviours from before to during the COVID-19 pandemic lockdown: a systematic review. Stockwell S, Trott M, Tully M, et al. BMJ Open Sport Exerc Med. 2021;7:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7852071</ArticleId><ArticleId IdType="pubmed">34192010</ArticleId></ArticleIdList></Reference><Reference><Citation>Effect of the COVID-19 pandemic on body weight in people at high risk of type 2 diabetes referred to the English NHS Diabetes Prevention Programme. Valabhji J, Barron E, Bradley D, Bakhai C, Khunti K, Jebb S. Lancet Diabetes Endocrinol. 2021;9:649–651.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8412796</ArticleId><ArticleId IdType="pubmed">34481556</ArticleId></ArticleIdList></Reference><Reference><Citation>A systematic scoping review on the consequences of stress-related hyperglycaemia. Olariu E, Pooley N, Danel A, Miret M, Preiser JC. PLoS One. 2018;13:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5889160</ArticleId><ArticleId IdType="pubmed">29624594</ArticleId></ArticleIdList></Reference><Reference><Citation>SARS-CoV-2 infects human pancreatic β cells and elicits β cell impairment. Wu CT, Lidsky PV, Xiao Y, et al. Cell Metab. 2021;33:1565–1576.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8130512</ArticleId><ArticleId IdType="pubmed">34081912</ArticleId></ArticleIdList></Reference><Reference><Citation>The high incidence of steroid-induced hyperglycaemia in hospital. Fong AC, Cheung NW. Diabetes Res Clin Pract. 2013;99:277–280.</Citation><ArticleIdList><ArticleId IdType="pubmed">23298665</ArticleId></ArticleIdList></Reference><Reference><Citation>Temporal trends in emergency admissions for diabetic ketoacidosis in people with diabetes in England before and during the COVID-19 pandemic: a population-based study. Misra S, Barron E, Vamos E, et al. Lancet Diabetes Endocrinol. 2021;9:671–680.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9765220</ArticleId><ArticleId IdType="pubmed">34481558</ArticleId></ArticleIdList></Reference><Reference><Citation>Trends in hospital admission for diabetic ketoacidosis in adults with type 1 and type 2 diabetes in England, 1998-2013: a retrospective cohort study. Zhong VW, Juhaeri J, Mayer-Davis EJ. Diabetes Care. 2018;41:1870–1877.</Citation><ArticleIdList><ArticleId IdType="pubmed">29386248</ArticleId></ArticleIdList></Reference><Reference><Citation>Diabetes-related excess mortality in Mexico: a comparative analysis of national death registries between 2017-2019 and 2020. Bello-Chavolla OY, Antonio-Villa NE, Fermín-Martínez CA, et al. Diabetes Care. 2022;45:2957–2966.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7613876</ArticleId><ArticleId IdType="pubmed">36286591</ArticleId></ArticleIdList></Reference><Reference><Citation>Evaluation of characteristics and outcomes for patients with diabetic ketoacidosis (DKA) with and without COVID-19 in Elmhurst Queens during similar three-month periods in 2019 and 2020. Patel U, Deluxe L, Salama C, Jimenez AR, Whiting A, Lubin C, Tarlin N. Cureus. 2021;13:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8364784</ArticleId><ArticleId IdType="pubmed">34414048</ArticleId></ArticleIdList></Reference><Reference><Citation>The impact of COVID-19 on diabetic ketoacidosis patients. Khan F, Paladino L, Sinert R. Diabetes Metab Syndr. 2022;16:102389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8736268</ArticleId><ArticleId IdType="pubmed">35016042</ArticleId></ArticleIdList></Reference><Reference><Citation>Comparison of diabetic ketoacidosis in adults during the SARS-CoV-2 outbreak and over the same time period for the preceding 3 years. Misra S, Khozoee B, Huang J, et al. Diabetes Care. 2021;44:0–31.</Citation><ArticleIdList><ArticleId IdType="pubmed">33334810</ArticleId></ArticleIdList></Reference><Reference><Citation>Hypoglycemia at the time of COVID-19 pandemic. Shah K, Tiwaskar M, Chawla P, Kale M, Deshmane R, Sowani A. Diabetes Metab Syndr. 2020;14:1143–1146.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7347476</ArticleId><ArticleId IdType="pubmed">32668399</ArticleId></ArticleIdList></Reference><Reference><Citation>The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 diabetes prone to hypoglycemia using standalone continuous glucose monitoring. Mesa A, Viñals C, Pueyo I 1st, Roca D, Vidal M, Giménez M, Conget I. Diabetes Res Clin Pract. 2020;167:108354.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392049</ArticleId><ArticleId IdType="pubmed">32739380</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>